Latest Platform Expansion News

Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.

Nanoveu has completed due diligence and is set to finalise its acquisition of EMASS, integrating cutting-edge AI-enabled SoC technology into its EyeFly3D™ platform to expand applications across wearables, IoT, and smart devices.